DeviceTalks Boston

Boston Convention and Exhibition Center
MA 02210, United States

May 27–28, 2026
Let’s meet at Booth 701
| 9:00 AM - 10:00 AM | Registration and Welcome |
| 10:00 AM - 10:30 AM | First Presention featured Speaker |
| 10:30 AM - 11:30 AM | Second Presention featured Speaker |
| day 2 | presentation one |
| day 2 | presentation two |
| day 3 | dinner |
| day 3 | networking |
| day 4 | some stuff |
| day 4 | some stuff |

































Unlock seamless interoperability in your organization with Infor Cloverleaf. As a leader, you understand the critical need for efficient data exchange to enhance care coordination and clinical outcomes. Cloverleaf breaks down barriers and empowers you to streamline connectivity and optimize operational efficiency, providing real-time insights for strategic decision-making. Transform your organization's data capabilities, stay ahead of CMS changes, and drive better healthcare outcomes with Cloverleaf.
• Visit our experts at booth 701








What if your medical devices could think, adapt, and communicate in real-time? Today, most medical devices operate in isolation—trapped in data silos, slowing workflows, and limiting artificial intelligence (AI)-driven insights. But with NVIDIA Holoscan and Infor Cloverleaf™, that’s about to change.
“I want a single dashboard that tells me how many ORs are running, who’s staffing each one, whether the equipment is ready, whether our supplies have arrived, what cases are on the schedule, and where we’re falling behind. Instead, we’re jumping between five different systems, radios, phone calls, and in-person conversations to pull that together.”
Dr. Jessica Feranec
Chief of Surgery, Orlando VA Medical Center
This white paper explores why the transition is accelerating, how interoperability platforms differ from traditional interface engines, and how adopting a platform model enables scalable, data-driven transformation.
Gain unparalleled insights into the life sciences landscape through aggregated data analysis, paving the way for accessible and targeted real-world evidence.